Compile Data Set for Download or QSAR
Report error Found 158 Enz. Inhib. hit(s) with all data for entry = 12056
TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674739BDBM674739(US20240158369, Compound 46 | US20240158369, Compou...)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674762BDBM674762(US20240158369, Compound 24)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674761BDBM674761(US20240158369, Compound 23)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674764BDBM674764(US20240158369, Compound 26)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674763BDBM674763(US20240158369, Compound 25)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674758BDBM674758(US20240158369, Compound 20)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674757BDBM674757(US20240158369, Compound 19)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674760BDBM674760(US20240158369, Compound 22)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674759BDBM674759(US20240158369, Compound 21)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674770BDBM674770(US20240158369, Compound 32)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674769BDBM674769(US20240158369, Compound 31)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674772BDBM674772(US20240158369, Compound 34)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674771BDBM674771(US20240158369, Compound 33)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674766BDBM674766(US20240158369, Compound 28)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674765BDBM674765(US20240158369, Compound 27)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674768BDBM674768(US20240158369, Compound 30)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674767BDBM674767(US20240158369, Compound 29)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674754BDBM674754(US20240158369, Compound 16)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674753BDBM674753(US20240158369, Compound 15)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674756BDBM674756(US20240158369, Compound 18)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674755BDBM674755(US20240158369, Compound 17)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674750BDBM674750(US20240158369, Compound 12)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674749BDBM674749(US20240158369, Compound 11)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674752BDBM674752(US20240158369, Compound 14)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674751BDBM674751(US20240158369, Compound 13)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674794BDBM674794(US20240158369, Compound 56)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674793BDBM674793(US20240158369, Compound 55)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674796BDBM674796(US20240158369, Compound 58)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674795BDBM674795(US20240158369, Compound 57)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674790BDBM674790(US20240158369, Compound 52)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674789BDBM674789(US20240158369, Compound 51)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674792BDBM674792(US20240158369, Compound 54)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674791BDBM674791(US20240158369, Compound 53)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674802BDBM674802(US20240158369, Compound 64)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674801BDBM674801(US20240158369, Compound 63)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674804BDBM674804(US20240158369, Compound 66)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674803BDBM674803(US20240158369, Compound 65)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674798BDBM674798(US20240158369, Compound 60)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674797BDBM674797(US20240158369, Compound 59)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674800BDBM674800(US20240158369, Compound 62)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674799BDBM674799(US20240158369, Compound 61)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674778BDBM674778(US20240158369, Compound 40)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674777BDBM674777(US20240158369, Compound 39)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674780BDBM674780(US20240158369, Compound 42)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674774BDBM674774(US20240158369, Compound 36)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674773BDBM674773(US20240158369, Compound 35)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674776BDBM674776(US20240158369, Compound 38)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674775BDBM674775(US20240158369, Compound 37)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674786BDBM674786(US20240158369, Compound 48)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Wigen Biomedicine Technology (Shanghai)

US Patent
LigandChemical structure of BindingDB Monomer ID 674785BDBM674785(US20240158369, Compound 47)
Affinity DataIC50: 10nMAssay Description:The inhibitory effect of the compounds on the enzyme activity of recombinant protein Wee-1 was determined by HTRF. The procedures are as follows: Aft...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2024
Entry Details
US Patent

Displayed 1 to 50 (of 158 total ) | Next | Last >>
Jump to: